Chart of the Week: Missed Biomarker Information Without Comprehensive Synonyms

by

This week’s Chart of the Week attempts to communicate recent research on the percent of results you are missing in your clinical information searches (e.g. pubmed, clinicaltrials.gov, etc) without utilizing  target and synonym technologies like in BiomarkerBase. This chart depicts how many relevant and potentially game changing trials and publications manual curation of literature is not finding compared to utilizing BiomarkerBase and its target synonym technology.

image-1.png

This preliminary data measures the percent of results you are not finding on respective search engines when not capitalizing on BiomarkerBase’s synonym technology. Clinicaltrials.gov and Pubmed.com barely scratch the surface of important literature when searching by general terms for a biomarker and disease correlation. In this Chart of the Week, the average percent of missed results is for a single biomarker and disease correlation. If you are managing multiple research projects, the amount of missed trials can be applied to each project. This will result in lack of precision in your findings as well as missing potentially key studies.

The percent of missed results is determined by manually searching for biomarker and disease correlations on Clinicaltrials.gov and Pubmed.com with the basic search terms versus utilizing the target synonyms in BiomarkerBase to capture all relevant trials and publications. High Evidence Biomarkers are considered those with large amounts of results in both Clinical Trials and Publications respectively.

Share this Image On Your Site

Please include attribution to Amplion.com with this graphic.

Chart of the Week: Percent of Missed Results Without BiomarkerBase Synonyms

PageLines

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access